Supernus Pharmaceuticals Inc
Closed
SectorHealthcare
46.82 5.28
Overview
Share price change
24h
Min
45.75
Max
47
Income | 36M -2.3M |
|---|---|
Sales | -3.9M 208M |
P/E Sector Avg | 48.435 50.958 |
EPS | 0.21 |
Profit margin | -1.104 |
Employees | 778 |
EBITDA | -70M 20M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +32.37% upside |
Next Earnings | 4 sie 2026 |
|---|
Market Cap | -219M 2.6B |
|---|---|
Previous open | 41.54 |
Previous close | 46.82 |
News Sentiment
By Acuity
98%
2%
319 / 342 Ranking in Healthcare
Supernus Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Supernus Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 62 USD 32.37%
High 66 USD
Low 55 USD
Based on 3 Wall Street analysts offering 12 month price targets forSupernus Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$